As we head into ASCO weekend, cancer experts will highlight closely watched data sets to be unveiled at the meeting. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing.

Featured Speakers

Jennifer Keating Litton, M.D.

Vice President of Clinical Research and Professor
The University of Texas MD Anderson Cancer Center

Jennifer Keating Litton, M.D., is Vice President of Clinical Research and Professor in the Department of Breast Medical Oncology and Clinical Cancer Genetics at The University of Texas MD Anderson Cancer Center.  She holds an additional faculty position in the Graduate School of Biomedical Sciences at The University of Texas Health Sciences Center in Houston.  She attended Duke University, with degrees in English and in History and The University of Massachusetts Medical School.  After completing an Internal Medicine Residency at Baylor College of Medicine, she then served as Chief Medical Resident.  She completed a fellowship in Medical Oncology at The University of Texas MD Anderson Cancer Center before joining the faculty in the Department of Breast Medical Oncology.  Her research interests include the treatment of young breast cancer patients, including the treatment of breast cancer during pregnancy, treatment-related infertility, hereditary cancer syndromes, immunotherapy and triple negative breast cancer.  She is the principle investigator for multiple clinical trials.  She serves as a member of the National Cancer Center Network National Guidelines Panel for Hereditary Breast and Ovarian Cancer Syndromes and has been appointed to the Breast Immuno-Oncology Task Force of the National Cancer Institute Breast Cancer Steering Committee and Co-Chair of the Society for Immunotherapy of Cancer (SITC) Breast Cancer Subcommittee.  She has authored multiple abstracts, peer-reviewed journal articles, and book chapters.  Dr. Litton has served on the boards of the St. Luke’s Episcopal Health Charities, the Children’s Fund, Suites of Hope and is an alumni of the Texas Lyceum.  She lives in Houston with her husband Todd and their three children.

Mike Riley

Regional Biologics President for North America
Catalent

Mike Riley is the Regional Biologics President for North America and has overall responsibility for strategy and management of the biologics business in North America. Previously, he served as Vice President/General Manager of Catalent Biologics for five years. Mike has 15 years of experience at Catalent where he has a demonstrated track record of strategic growth leadership across multiple businesses, previously serving as Vice President of Strategy, Advanced Delivery Technologies and Vice President, Global Business Development for Catalent Sterile Technologies. Prior to joining Catalent, Mike worked as a management consultant for Marakon Associates, providing strategic advisory to companies across multiple industries. Mike holds a B.A. from Duke University, and a MBA from The Wharton School, University of Pennsylvania.

 

Sponsored by: 

Catalent-logo-2018.png                

Date:  Thursday, June 3, 2021
Time:  2pm ET / 11am PT
Duration:  1 Hour

Register now for this roundtable